These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8230241)

  • 1. The myocardial vasculature during ischemia and reperfusion: a target for injury and protection.
    Hearse DJ; Maxwell L; Saldanha C; Gavin JB
    J Mol Cell Cardiol; 1993 Jul; 25(7):759-800. PubMed ID: 8230241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial dysfunction contributes to myocardial depression in ischemia-reperfusion in the rat.
    Qi XL; Nguyen TL; Andries L; Sys SU; Rouleau JL
    Can J Physiol Pharmacol; 1998 Jan; 76(1):35-45. PubMed ID: 9564547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion.
    Reffelmann T; Kloner RA
    Basic Res Cardiol; 2006 Sep; 101(5):359-72. PubMed ID: 16915531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
    Vinten-Johansen J
    Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin.
    Kalweit GA; Schipke JD; Godehardt E; Gams E
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):1011-8. PubMed ID: 11689808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular in vivo assessment of reperfusion injury: significance of prostaglandin E(1) and I(2) in postischemic "no-reflow" and "reflow-paradox".
    Tauber S; Menger MD; Lehr HA
    J Surg Res; 2004 Jul; 120(1):1-11. PubMed ID: 15172184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microcirculation of skeletal muscle after ischemia and reperfusion].
    Menger MD; Messmer K
    Wien Med Wochenschr; 1993; 143(7-8):148-58. PubMed ID: 8379164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary endothelial cells: a target of ischemia reperfusion and its treatment?
    Laude K; Richard V; Thuillez C
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):250-4. PubMed ID: 15106748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of microvascular resistance in physiological conditions and reperfusion.
    DeFily DV
    J Mol Cell Cardiol; 1998 Dec; 30(12):2547-54. PubMed ID: 9990526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of endothelium-dependent relaxations four weeks after ischemia and progressive reperfusion in canine coronary arteries.
    Lee JJ; Olmos L; Vanhoutte PM
    Proc Assoc Am Physicians; 1996 Sep; 108(5):362-7. PubMed ID: 8902880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A poly(ADP-ribose) synthetase inhibitor, benzamide protects smooth muscle cells but not endothelium against ischemia/reperfusion injury in isolated guinea-pig heart.
    Jakubowski A; Lomnicka M
    Acta Biochim Pol; 2007; 54(1):199-204. PubMed ID: 17369883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous bradykinin enhances ischemia/reperfusion injury of pancreas in rats.
    Hoffmann TF; Steinbauer M; Waldner H; Messmer K
    J Surg Res; 1996 Apr; 62(1):144-51. PubMed ID: 8606502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural evidence of increased tolerance of hibernating myocardium to cardioplegic ischemia-reperfusion injury.
    Milei J; Fraga CG; Grana DR; Ferreira R; Ambrosio G
    J Am Coll Cardiol; 2004 Jun; 43(12):2329-36. PubMed ID: 15193702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fibrinolysis during reperfusion of ischemic skeletal muscle.
    Quiñones-Baldrich WJ
    Microcirc Endothelium Lymphatics; 1989; 5(3-5):299-314. PubMed ID: 2637946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ischemic preconditioning of the myocardium: the role of changes in the permeability of the coronary microcirculation].
    Di Napoli P; Di Muzio M; Contegiacomo G; Tiloca P; Spoletini L; Di Crecchio A; Gallina S; Barsotti A
    Cardiologia; 1997 Jan; 42(1):59-67. PubMed ID: 9118156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of interstitial myocardium in ischemia-reperfusion injury: experimental data and clinical implications].
    Barsotti A; Di Napoli P; Di Girolamo E; Di Muzio M; Vitullo P; Dini FL; Gallina S; Modesti A
    Cardiologia; 1994 Dec; 39(12 Suppl 1):381-8. PubMed ID: 7634300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular pathophysiology of skeletal muscle ischemia-reperfusion.
    Durán WN; Takenaka H; Hobson RW
    Semin Vasc Surg; 1998 Sep; 11(3):203-14. PubMed ID: 9763120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of reperfusion following ischemia on microvessels and microcirculation of skeletal muscle].
    Xing X; Guo E; Xu F
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1997 Jul; 11(4):242-6. PubMed ID: 9867992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.
    Pemberton M; Anderson G; Vĕtvicka V; Justus DE; Ross GD
    J Immunol; 1993 Jun; 150(11):5104-13. PubMed ID: 8496606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.